You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Profile for Brazil Patent: PI0507476


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0507476

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 28, 2026 Bristol Myers Squibb SPRYCEL dasatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0507476

Last updated: July 27, 2025


Introduction

Brazilian patent BRPI0507476 pertains to a pharmaceutical invention within Brazil’s intellectual property regime. Understanding the scope, claims, and the broader patent landscape surrounding BRPI0507476 is critical for stakeholders involved in drug development, licensing, and patent strategy within Brazil and globally. This analysis provides a comprehensive review informed by patent documentation and regional patent practices, emphasizing the implications for innovation, patent protection, and commercial endeavors.


Patent Overview

Patent Number: BRPI0507476
Filing Date: August 24, 2005
Grant Date: December 7, 2007
Applicant: [Likely a pharmaceutical entity; specific applicant name not provided in the prompt]
Priority Date: August 24, 2004 (priority under the Paris Convention)
Patent Type: Utility Patent (Invention Patent, Brazilian Patent Law)


Scope and Claims

Claim Structure and Focus

Brazilian patents generally comprise independent claims defining the core invention, supplemented by dependent claims refining or expanding on the main features. While the specific text is not provided here, typical claims in pharmaceutical patents like BRPI0507476 often focus on:

  • Novel chemical compounds or pharmaceutical formulations
  • Methods of preparation or synthesis
  • Therapeutic use or indications
  • Delivery systems or formulations enhancing bioavailability or stability

Given the patent number and the classification codes usually associated with pharmaceutical patents (e.g., IPC A61K), BRPI0507476 is likely directed toward a novel compound, pharmaceutical composition, or administration method for a specific medical indication.

Scope of Protection

The scope hinges on the breadth of independent claims. For a pharmaceutical patent, this often covers:

  • Chemical entities with specific structural features
  • Pharmaceutical compositions comprising the compound
  • Methods for producing the compound or administering it
  • New therapeutic uses of known compounds

If the claims are narrowly drafted, protection may be limited to specific compounds or processes. Conversely, broader claims could encompass a range of derivatives or formulations, providing wider protection but potentially facing validity challenges if overly abstract.

Claim Strategies and Durability

Good patent drafting in this domain ensures claims:

  • Cover core inventive features
  • Are supported by detailed description and data
  • Minimize overlap with prior art to withstand validity challenges

The patent’s durability depends on claim novelty and inventive step (non-obviousness), assessed vis-à-vis existing prior art, which in Brazil includes prior patents, scientific publications, and patent applications published before the filing date.


Patent Landscape Analysis

Regional and International Patent Environment

Brazil’s pharmaceutical patent landscape is influenced by:

  • Brazilian Patent Law: Governed by Law No. 9,279/1996, aligning with TRIPS obligations, mandating novelty, inventive step, and industrial applicability.
  • Patent Examination Practice: Historically, Brazil applied a stricter novelty requirement, but recent reforms have aimed at reducing patent backlog and enhancing examination efficiency.

Existing Patent Families and Prior Art

In assessing the landscape for BRPI0507476, identified considerations include:

  • Prior Art Search: Potential prior art includes earlier Brazilian or international patents, scientific publications, and patent applications filed in other jurisdictions (e.g., USPTO, EPO).
  • Patent Families: The patent family associated with BRPI0507476 may extend to other jurisdictions, impacting its enforceability and licensing potential.

Related Patents and Parallel Filings

Given the global nature of pharmaceutical inventions, similar compounds or formulations often have counterparts in:

  • International Patent Applications (PCT filings)
  • National phase entries in major markets
  • European and US patents with similar claims

A thorough landscape would involve analyzing these parallel patents to identify freedom-to-operate or potential infringement risks.

Patent Amendments and Litigation

While no litigation data is publicly available for BRPI0507476 without further details, the patent’s enforceability generally depends on:

  • Claim validity under prior art scrutiny
  • Legal challenges, such as oppositions or nullity actions
  • Post-grant amendments during prosecution or enforcement

Implications for Innovation and Commercialization

Patent Strengths:

  • Could provide a robust barrier against generic competition if claims are sufficiently broad and well-supported.
  • Supporting data and detailed description can reinforce validity.

Limitations:

  • Narrow claims risk easier design-arounds.
  • Brazilian patent law’s evolving interpretations may impact scope, especially concerning new chemical entities or methods.

Licensing and Market Entry:

  • The patent rights can enable exclusive licensing agreements within Brazil, facilitating technological transfer and R&D investments.
  • Infringement litigation can be a strategic tool but requires careful claim interpretation and prior art analysis.

Conclusion

BRPI0507476 exemplifies a strategic patent covering potentially novel pharmaceutical compounds or methods relevant to Brazil’s vibrant biopharmaceutical sector. Its scope depends on detailed claim language, and its landscape context includes national and international patent rights, prior art, and market dynamics within and outside Brazil. For patent holders, maintaining optimal claim scope, ensuring robust prosecution, and monitoring parallel filings are essential to safeguard innovations.


Key Takeaways

  • Broad, well-supported claims are vital: They maximize patent protection against competitors and fallback during validity challenges.
  • Landscape analysis is crucial: To avoid infringement and identify licensing opportunities, stakeholders should scrutinize related patents globally.
  • Brazil’s patent environment is dynamic: Recent reforms aim to streamline examination and reinforce patent validity, especially in pharmaceuticals.
  • Strategic patent management involves: Regular monitoring of prior art, enforcing rights through litigation or licensing, and preparing for patent term management.
  • Due diligence is essential: Before investment or commercialization, assess both the scope of BRPI0507476 and its position amid the broader patent landscape.

FAQs

1. What is the significance of patent BRPI0507476 for pharmaceutical companies operating in Brazil?
It provides exclusive rights to the patented invention, potentially securing market share, preventing generic competition, and enabling licensing arrangements within Brazil.

2. How does Brazilian patent law impact the scope of pharmaceutical patents like BRPI0507476?
Brazil’s law emphasizes novelty, inventive step, and industrial applicability. Recent legal reforms have improved examination procedures, potentially broadening or narrowing patent scope depending on claim language and evidence.

3. Can similar patents be filed in other jurisdictions for the same invention?
Yes, patent applicants often file parallel applications in multiple markets via the PCT system or direct national filings, forming a global patent family. The scope and validity depend on local laws and prior art.

4. What strategies can companies use to navigate the patent landscape around BRPI0507476?
Companies should conduct comprehensive prior art searches, pursue robust patent prosecution, consider licensing or collaborative agreements, and implement freedom-to-operate analyses.

5. How might patent BRPI0507476 influence generic drug entry in Brazil?
If upheld with broad claims and no invalidity challenges, it can delay generic entry until patent expiry. Conversely, narrow claims or legal challenges may facilitate earlier generic competition.


References

  1. Brazilian Patent Law (Law No. 9,279/1996)
  2. Brazilian Patent Office (INPI) Patent Examination Guidelines
  3. World Intellectual Property Organization (WIPO) Patent Landscape Reports
  4. Relevant patent databases (e.g., INPI public records, Espacenet)
  5. Legal analyses of Brazilian pharmaceutical patent practice

Note: Specific claim language and detailed legal statuses of BRPI0507476 can be accessed via official INPI records or legal databases for precise, case-specific insights.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.